LNTH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Lantheus Holdings Inc (LNTH) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has positive growth prospects in the medium to long term, the current technical indicators, financial performance, and trading sentiment do not support an immediate buy decision. It is better to hold off for now and monitor for more favorable entry points.
The MACD is negative and contracting, RSI is neutral at 45.585, and moving averages are converging, indicating no strong trend. The stock is trading near its pivot level of 77.599, with support at 74.676 and resistance at 80.521, suggesting limited short-term upside.
Analyst ratings are predominantly positive, with multiple upgrades and price target increases, reflecting optimism about the company's long-term growth potential driven by its PSMA PET model and Pylarify product pipeline.
Hedge funds and insiders are selling heavily, with insider selling up by 5211.12% in the last month. Additionally, the company's financial performance in Q4 2025 showed a significant decline in net income (-558.76%) and EPS (-576.47%), raising concerns about near-term profitability.
In Q4 2025, revenue increased by 4.01% YoY to $406.79M, but net income dropped significantly to $54.09M (-558.76% YoY), and EPS fell to 0.81 (-576.47% YoY). Gross margin also declined to 59.21%, down 6.83% YoY, indicating margin pressure.
Analysts remain optimistic about LNTH, with multiple firms raising price targets (e.g., Jefferies to $110, Truist to $89, Mizuho to $85) and maintaining buy/outperform ratings. However, one downgrade to Hold by JonesResearch highlights concerns about short-term valuation and fiscal 2026 revenue contributions.
